• Kura Oncology Chief Legal Officer Teresa Brophy Bair sold 2,256 common shares on May 18, 2026 at a weighted average price of $9.38.
• Holdings stood at 226,931 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-232546), on May 20, 2026, and is solely responsible for the information contained therein.